MD Anderson Cancer Center
Houston, Texas, 77030, United States
Location contact
Eileen D Hacker, MD
CONTACT
Eileen D Hacker, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07610499
To learn if the Creating Opportunities for Personal Empowerment (COPE) intervention is feasible, acceptable, and helpful (compared to usual care) in women with breast cancer who are receiving first line treatment.
Trial opening soon.
Get Notified18 year and older
Female
Interventional
Not applicable
Houston, Texas, 77030, United States
Eileen D Hacker, MD
CONTACT
Eileen D Hacker, MD
PRINCIPAL_INVESTIGATOR
Primary Objectives The primary objective of this study is to assess the feasibility and acceptability of the COPE intervention, a nurse-led cognitive-behavioral skills-building intervention, in women undergoing their first line of treatment for breast cancer.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Eligibility Criteria
Exclusion criteria
Given by Questionnaires
7 week sessions
Time frame: Through study completion; an average of 1 year
Contact information is provided by the study sponsor or research team.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619534
Breast Cancer, Breast Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT07737132
Breast Cancer, Breast Diseases
View Trial DetailsNCT07737951
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07732101
Atrophy, Breast Cancer
Beijing, Beijing Municipality, China
View Trial Details